Skip to main content

and
  1. Article

    Open Access

    Development and characterization of NILK-2301, a novel CEACAM5xCD3 κλ bispecific antibody for immunotherapy of CEACAM5-expressing cancers

    T-cell retargeting to eliminate CEACAM5-expressing cancer cells via CEACAM5xCD3 bispecific antibodies (BsAbs) showed limited clinical activity so far, mostly due to insufficient T-cell activation, dose-limitin...

    Anja Seckinger, Sara Majocchi, Valéry Moine in Journal of Hematology & Oncology (2023)

  2. Article

    Open Access

    Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG

    Bispecific antibodies enable unique therapeutic approaches but it remains a challenge to produce them at the industrial scale, and the modifications introduced to achieve bispecificity often have an impact on ...

    Nicolas Fischer, Greg Elson, Giovanni Magistrelli, Elie Dheilly in Nature Communications (2015)

  3. No Access

    Article

    GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins

    Engineered mammalian cells express glycoproteins with reduced glycan heterogeneity.

    Leander Meuris, Francis Santens, Greg Elson, Nele Festjens in Nature Biotechnology (2014)

  4. No Access

    Article

    OmpA targets dendritic cells, induces their maturation and delivers antigen into the MHC class I presentation pathway

    We analyzed the interaction between a bacterial cell wall protein and dendritic cells (DCs). Outer membrane protein A from Klebsiella pneumoniae (kpOmpA) specifically bound to professional antigen presenting cell...

    Pascale Jeannin, Toufic Renno, Liliane Goetsch, Isabelle Miconnet in Nature Immunology (2000)

  5. No Access

    Article

    Detection of a polymorphism in exon 8 of the human CD86 gene

    Yves Delneste, Roberta Bosotti, Giovanni Magistrelli, Jean-Yves Bonnefoy in Immunogenetics (2000)